DORCHESTER WEALTH MANAGEMENT Co lifted its holdings in shares of Medtronic plc (NYSE:MDT – Free Report) by 3.0% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 6,072 shares of the medical technology company’s stock after purchasing an additional 175 shares during the period. DORCHESTER WEALTH MANAGEMENT Co’s holdings in Medtronic were worth $547,000 as of its most recent filing with the SEC.
Several other institutional investors and hedge funds also recently made changes to their positions in MDT. Lynx Investment Advisory purchased a new position in shares of Medtronic in the second quarter worth $28,000. Tributary Capital Management LLC purchased a new position in shares of Medtronic in the first quarter valued at about $33,000. Gleason Group Inc. bought a new position in shares of Medtronic during the second quarter valued at about $42,000. Opal Wealth Advisors LLC purchased a new stake in shares of Medtronic during the second quarter worth about $43,000. Finally, Olistico Wealth LLC bought a new stake in shares of Medtronic in the second quarter worth about $45,000. Institutional investors own 82.06% of the company’s stock.
Medtronic Stock Down 0.2 %
Shares of MDT stock traded down $0.20 during mid-day trading on Thursday, hitting $92.07. The company’s stock had a trading volume of 755,548 shares, compared to its average volume of 6,214,059. The stock has a market cap of $118.06 billion, a price-to-earnings ratio of 33.55, a PEG ratio of 2.53 and a beta of 0.84. The company has a debt-to-equity ratio of 0.55, a quick ratio of 1.61 and a current ratio of 2.13. Medtronic plc has a 52-week low of $68.84 and a 52-week high of $92.66. The business has a 50-day moving average price of $89.04 and a 200 day moving average price of $83.74.
Medtronic Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Friday, October 11th. Shareholders of record on Friday, September 27th were given a $0.70 dividend. The ex-dividend date of this dividend was Friday, September 27th. This represents a $2.80 annualized dividend and a yield of 3.04%. Medtronic’s payout ratio is 101.82%.
Analyst Ratings Changes
Several equities analysts have recently issued reports on the company. Oppenheimer boosted their target price on Medtronic from $92.00 to $94.00 and gave the company a “market perform” rating in a research note on Wednesday, August 21st. Needham & Company LLC restated a “hold” rating on shares of Medtronic in a report on Tuesday, August 20th. Royal Bank of Canada raised shares of Medtronic from a “sector perform” rating to an “outperform” rating and lifted their target price for the company from $98.00 to $105.00 in a research note on Thursday, October 10th. Piper Sandler boosted their price target on shares of Medtronic from $85.00 to $90.00 and gave the company a “neutral” rating in a research report on Wednesday, August 21st. Finally, Truist Financial lifted their price objective on Medtronic from $90.00 to $93.00 and gave the company a “hold” rating in a research report on Monday, October 14th. One equities research analyst has rated the stock with a sell rating, eight have assigned a hold rating, six have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $95.36.
Get Our Latest Stock Analysis on MDT
About Medtronic
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software.
Featured Articles
- Five stocks we like better than Medtronic
- Russell 2000 Index, How Investors Use it For Profitable Trading
- A $1.75 Billion Gamble: Can Lucid Ignite Growth?
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- The Rally in Lockheed Martin and RTX Can Continue: Here’s Why
- The Risks of Owning Bonds
- 3 Undervalued Technology Stocks With Big Rebound Potential
Want to see what other hedge funds are holding MDT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Medtronic plc (NYSE:MDT – Free Report).
Receive News & Ratings for Medtronic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medtronic and related companies with MarketBeat.com's FREE daily email newsletter.